EUVIMEDEUVIMED entdecken
Crossref

Dual roles of sphingosine-1-phosphate receptor 3 in inflammation, ischemia-reperfusion injury, and vascular homeostasis

Yichen He, Xiangyi Zhang, Qin Zhang, Weiqi Lin, Yan Zhang, Haiyi Qian, Wen Ke, Qun Chen, Xiaolong Yuan, Cuifeng Zhang

Perioperative Precision Medicine · 26.06.2026 · 4 (2) · 225-243

DOI: 10.61189/479035poxawz ↗

Kurz gefasst

Fachartikel in der Zeitschrift Perioperative Precision Medicine, online erschienen am 26.06.2026. Verfasst von Yichen He und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sphingosine-1-phosphate receptor 3 (S1PR3) is a member of the G protein-coupled receptor (GPCR) family, structurally characterized by seven transmembrane domains. It exhibits diverse biological functions by binding to three major Gα protein subtypes (Gi/o, Gq, and G12/13), thereby activating downstream signaling pathways such as phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt), phospholipase C/calcium (PLC/Ca²⁺), and Ras homolog family member A/Rho-associated coiled-coil containing protein kinase (RhoA/ROCK). S1PR3 displays tissue- and cell-specific expression patterns, with high levels observed in the cardiovascular system (endothelial cells, vascular smooth muscle cells, cardiac fibroblasts), immune system (macrophages, dendritic cells), nervous system (astrocytes, microglia), and liver (hepatocytes, hepatic stellate cells). This expression profile enables S1PR3 to play pivotal roles in regulating inflammation, maintaining vascular homeostasis, repairing liver damage, protecting neural function, and preserving immune balance. Under pathological conditions, S1PR3 exhibits dual functionality. At physiological concentrations or under mild pathological conditions, it exerts protective effects—for instance, preventing cardiomyocyte and hepatocyte apoptosis and maintaining blood-brain barrier (BBB) integrity. Conversely, overactivation leads to tissue damage, including exacerbated inflammatory infiltration (e.g., in acute respiratory distress syndrome, ARDS), promotion of fibrosis (e.g., hepatic fibrosis), and vascular injury (e.g., atherosclerosis). S1PR3 has emerged as a promising therapeutic target for cardiovascular diseases, neurological injuries, and liver disorders. However, clinical application of S1PR3 modulators is hindered by off-target effects (e.g., bradycardia due to insufficient subtype selectivity) and risks of immunosuppression, underscoring the need for more selective ligands and personalized therapeutic regimens.

Zitieren

APA

He, Y., Zhang, X., Zhang, Q., Lin, W., Zhang, Y., Qian, H., Ke, W., Chen, Q., Yuan, X., & Zhang, C. (2026). Dual roles of sphingosine-1-phosphate receptor 3 in inflammation, ischemia-reperfusion injury, and vascular homeostasis. Perioperative Precision Medicine, 4(2), 225-243. https://doi.org/10.61189/479035poxawz

Vancouver

He Y, Zhang X, Zhang Q, Lin W, Zhang Y, Qian H, et al. Dual roles of sphingosine-1-phosphate receptor 3 in inflammation, ischemia-reperfusion injury, and vascular homeostasis. Perioperative Precision Medicine. 2026;4(2):225-243. doi:10.61189/479035poxawz

BibTeX
@article{He2026,
  author = {He, Yichen and Zhang, Xiangyi and Zhang, Qin and Lin, Weiqi and Zhang, Yan and Qian, Haiyi and Ke, Wen and Chen, Qun and Yuan, Xiaolong and Zhang, Cuifeng},
  title = {Dual roles of sphingosine-1-phosphate receptor 3 in inflammation, ischemia-reperfusion injury, and vascular homeostasis},
  journal = {Perioperative Precision Medicine},
  year = {2026},
  volume = {4},
  number = {2},
  pages = {225--243},
  doi = {10.61189/479035poxawz}
}
Kostenlos starten →